Publikation: Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice
Lade...
Dateien
Datum
2014
Autor:innen
Whitehead, Mark
Almajhdi, Fahad N.
Alloza, Leonor
Marzábal, Pablo
Meyers, Ann E.
Hitzeroth, Inga I.
Rybicki, Edward P.
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Gold
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
BMC Cancer. 2014, 14, 367. eISSN 1471-2407. Available under: doi: 10.1186/1471-2407-14-367
Zusammenfassung
Human papillomaviruses (HPV) are the causative agents of cervical cancer in women, which results in over 250 000 deaths per year. Presently there are two prophylactic vaccines on the market, protecting against the two most common high-risk HPV types 16 and 18. These vaccines remain very expensive and are not generally affordable in developing countries where they are needed most. Additionally, there remains a need to treat women that are already infected with HPV, and who have high-grade lesions or cervical cancer.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
Cervical cancer; DNA vaccine; HPV-16; E7; Zera® protein; Protein body; Plant-produced
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690
WHITEHEAD, Mark, Peter ÖHLSCHLÄGER, Fahad N. ALMAJHDI, Leonor ALLOZA, Pablo MARZÁBAL, Ann E. MEYERS, Inga I. HITZEROTH, Edward P. RYBICKI, 2014. Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice. In: BMC Cancer. 2014, 14, 367. eISSN 1471-2407. Available under: doi: 10.1186/1471-2407-14-367BibTex
@article{Whitehead2014Human-30632,
year={2014},
doi={10.1186/1471-2407-14-367},
title={Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice},
volume={14},
journal={BMC Cancer},
author={Whitehead, Mark and Öhlschläger, Peter and Almajhdi, Fahad N. and Alloza, Leonor and Marzábal, Pablo and Meyers, Ann E. and Hitzeroth, Inga I. and Rybicki, Edward P.},
note={Article Number: 367}
}RDF
<rdf:RDF
xmlns:dcterms="http://purl.org/dc/terms/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
xmlns:bibo="http://purl.org/ontology/bibo/"
xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
xmlns:foaf="http://xmlns.com/foaf/0.1/"
xmlns:void="http://rdfs.org/ns/void#"
xmlns:xsd="http://www.w3.org/2001/XMLSchema#" >
<rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/30632">
<dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dc:rights>terms-of-use</dc:rights>
<dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
<dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/30632/3/Whitehead_0-285260.pdf"/>
<dc:creator>Almajhdi, Fahad N.</dc:creator>
<dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2015-04-01T06:14:48Z</dc:date>
<dc:creator>Hitzeroth, Inga I.</dc:creator>
<dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2015-04-01T06:14:48Z</dcterms:available>
<dc:contributor>Meyers, Ann E.</dc:contributor>
<dc:creator>Alloza, Leonor</dc:creator>
<dc:contributor>Rybicki, Edward P.</dc:contributor>
<dc:contributor>Alloza, Leonor</dc:contributor>
<dc:contributor>Whitehead, Mark</dc:contributor>
<dc:language>eng</dc:language>
<dc:contributor>Almajhdi, Fahad N.</dc:contributor>
<foaf:homepage rdf:resource="http://localhost:8080/"/>
<dcterms:abstract xml:lang="eng">Human papillomaviruses (HPV) are the causative agents of cervical cancer in women, which results in over 250 000 deaths per year. Presently there are two prophylactic vaccines on the market, protecting against the two most common high-risk HPV types 16 and 18. These vaccines remain very expensive and are not generally affordable in developing countries where they are needed most. Additionally, there remains a need to treat women that are already infected with HPV, and who have high-grade lesions or cervical cancer.</dcterms:abstract>
<dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/30632/3/Whitehead_0-285260.pdf"/>
<dcterms:issued>2014</dcterms:issued>
<void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
<dc:contributor>Hitzeroth, Inga I.</dc:contributor>
<dcterms:title>Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice</dcterms:title>
<dc:contributor>Öhlschläger, Peter</dc:contributor>
<dc:creator>Meyers, Ann E.</dc:creator>
<bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/30632"/>
<dc:creator>Whitehead, Mark</dc:creator>
<dc:creator>Öhlschläger, Peter</dc:creator>
<dc:contributor>Marzábal, Pablo</dc:contributor>
<dc:creator>Rybicki, Edward P.</dc:creator>
<dc:creator>Marzábal, Pablo</dc:creator>
</rdf:Description>
</rdf:RDF>Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
